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ABSTRACT  
Aims 
Growth charts for cerebral palsy (CP) have been constructed using data for 24,920 
Californian patients, covering ages 2-20 years, with separate charts for the five Gross Motor 
Function Classification System (GMFCS) severity levels. Our aim was to test how British 
children with CP fit these charts, compared to conventional local charts.   
Methods  
The US CP growth reference was reanalyzed using the LMS (Lambda-Mu-Sigma) method to 
allow calculation of standard deviation (Z) scores.  Growth data for 195 children in Glasgow 
with CP were retrieved and converted to Z scores using the CP reference as well as the UK-
WHO growth reference.  
Results  
Measurements diverged progressively from the UK-WHO reference with increasing severity, 
with mean height for GMFCS V being close to the 2nd UK-WHO percentile. Compared to the 
CP reference mean height and weight Z scores were between 50th and 75th for all severity 
levels, while BMI was just below the 50th percentile.   
Interpretation 
British children with severe CP appear very small when plotted on non-CP charts, but fit well 
to US CP charts for weight and BMI and reasonably well for height. The LMS look-up tables 
will make it possible to calculate Z scores and produce charts in local formats. 
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What This Study Adds 
 
 Children with severe cerebral palsy (CP) appear very small when plotted on standard 
charts 
 UK children with CP fit well to US CP charts for weight and BMI 
 UK children with CP appear tall relative to US CP charts for height  
 It is now possible to calculate CP Z scores and produce charts in local formats. 
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BACKGROUND 
Cerebral palsy (CP) is one of the most common physical disabilities in children, with a 
prevalence of around 2 per 1,000 children.1  It is characterized by a variable degree of motor 
and postural impairment due to a non-progressive insult to the developing brain, which is also 
commonly accompanied by cognitive or sensory impairment2. Healthcare professionals use 
growth charts as a tool for monitoring how a child is growing in comparison to children of 
the same age and sex and to identify children whose weight or height falls significantly below 
normal percentiles, which may indicate the need for investigation or treatment. It has been 
known for some time that children with severe CP do not grow or gain weight as expected for 
unaffected children3. CP is commonly associated with feeding difficulty, due to oromotor 
impairment, affecting the ability to chew and swallow safely4 and the extent of feeding 
difficulty has been shown to predict growth outcomes5.  The wider recognition of this has led 
to many children receiving gastrostomy tube feeding in recent years, with clear benefits for 
their state of nutrition and quality of life6 7. However, despite gastrostomy feeding, many 
children with severe CP remain very small, leading to recognition that even with even with 
careful clinical nutritional monitoring and intervention nutrition, children with severe 
cerebral palsy grow slowly for intrinsic rather than nutritional reasons.   
A large study of children with CP who had accessed the services provided by the 
California Department of Developmental Services within a 15-year period, 1988-2002, 
summarized the growth of 24,920  children and found clear gradients for height and weight 
between the most and the least severe8.  The same group used these data to develop growth 
charts for height, weight and BMI, specifically for children with CP aged 2 to 20 years9. 
Charts showing percentiles for height-for-age, weight-for-age and BMI-for-age were 
statistically modeled using 141,961 measurements of height and weight.  Specific charts were 
developed, for both genders, for each of the five levels of the Gross Motor Function 
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Classification System (GMFCS) for severity of CP motor involvement 10; level 5, 
representing the most severe motor disability was further stratified by the presence or not of a 
feeding tube. Thus there were a total of twelve separate growth charts.  
Although published in 2011 there has so far only been one published validation of the weight 
curves11 and their international relevance is unclear.  Our aim therefore was to retrieve a 
growth data set for British children with CP in order to explore how well they fit the US CP 
charts compared to the mainstream UK charts. 
METHODS  
Patients 
The NHS Greater Glasgow and Clyde Community Pediatric Services have a large caseload of 
children with CP, seen first usually to make the diagnosis and then monitored through the 
school years to coordinate their care needs.  All contacts with children managed by GGC 
Community Pediatric Services were recorded in their Support Needs System electronic 
database.  All children with CP diagnosis recorded within that database born between 1997 
and 2013 were identified and available weight and height data downloaded.  All weights were 
recorded on electronic, clinical grade standing, sitting or wheelchair scales. Standing height 
was measured where possible, usually using a wall mounted measure with a rigid T piece or 
occasionally a rigid free standing scale.  Children who could not stand were measured using a 
flexible rule laid on the couch under the child. Lengths were not usually measured at all 
where children had fixed contractures to both legs, were too long for the measurer or too 
heavy to lift.  
For children with any growth data the child’s consulting supervising community pediatrician 
was contacted and asked to notify us both of their GMFCS level and whether they were tube 
fed. These records were also linked to a specialized CP database which included some but not 
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all the children managed by the service, where GMFCS level was recorded, but not tube 
feeding status.   
The GMFCS levels were defined as follows12: 
 Level I: Walks without restrictions; limitations in more advanced gross motor skills 
 Level II: Walks without assistive devices; limitations in walking outdoors and in the 
community 
 Level III: Walks with assistive mobility devices; limitations in walking outdoors and 
in the community 
 Level IV: Self-mobility with limitations; children are transported or use power 
mobility outdoors and in the community 
 Level V-NT: Self-mobility is severely limited even with the use of assistive 
technology, though not tube fed 
 Level V-TF: Level V-NT and tube fed.  
Enteral feeding turned out to be poorly recorded, and some children started or stopped tube 
feeding as they got older . So for our purposes the two level V categories were merged and 
plotted in V-NT charts. Once the data were matched to a GMFCS level child identifiers were 
deleted  and the analyses were undertaken on this anonymized data set. The analysis was 
classified as service evaluation, so no ethical permissions were required.  
Further analysis of the US source data 
The US CP charts were constructed using Generalized Additive Models for Scale and Shape 
(GAMLSS) and the Box-Cox-Power-Exponential (BCPE) distribution family13 as 
implemented with the gamlss package13 in the R language The fitted chart percentiles (from 
the 1st through to the 99th) were tabulated by age in tenths of a year from 2 to 20 years, giving 
tables with 181 rows and 99 columns. There were separate tables of weight, height and BMI 
by sex, for each of the GMFCS levels. The advantage of this approach was that the 
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percentiles were adjusted for distributional skewness and kurtosis, but the disadvantage was 
the lack of convenient software to convert the measurements and percentiles to exact standard 
deviation (Z) scores. 
For the present analysis the tables were recalculated to match tables for the LMS 
method 14, using the LMSfit function in the sitar package.  The LMS method corresponds to 
the GAMLSS Box-Cox Cole-Green (BCCG) family, a special case of the BCPE family that 
adjusts for distributional skewness but not kurtosis. However in practice BCPE percentiles 
are usually very similar to LMS/BCCG percentiles, and any differences are restricted to the 
most extreme (i.e. top and bottom) percentiles. This reanalysis converted the references to 
LMS tables compatible with LMSgrowth11 software, which in turn allowed a) individual 
measurements to be converted to Z scores, and b) the GMFCS chart percentiles to be adjusted 
to match the UK 9 percentile format15. It also meant that the GMFCS charts could be 
compared directly with the UK-WHO charts, the combined World Health Organization and 
UK 1990 growth reference as used in the UK for school age children16.  A small pilot of 
manual plotting on the GMFCS IV and V charts suggested that the fit to the charts was 
reasonable, but that data for a wider range of ages and severities were needed.     
Analysis of data from the UK cohort 
Anthropometric measures for children with known GMFCS levels were converted to Z scores 
using LMSgrowth software17, both on the relevant GMFCS chart and the UK-WHO chart.  
These data were first analyzed per measurement, as the larger numbers allowed examination 
of narrow age categories as well as all the GMFCS levels. In addition, the Z scores for weight 
and height were averaged by child, along with the mean ages of measurement, and the 
analyses were then repeated for the child means. 
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We defined the fit to either reference in terms of the discrepancy of the mean value 
from the expected zero as described in a recent paper: 18 a poor fit being a discrepancy of 
greater than 0.67 standard deviations (SD) and a good fit being within 0.33 SD.   
We hypothesized that compared to UK-WHO, children with mild CP would fit well 
on average, but that percentiles would be progressively lower with greater CP severity, and 
more so with increasing age.  Compared to the CP reference we hypothesized that the CP 
children would on average be close to average for all grades of severity, with no variation by 
age.  However we also had to consider the possibility that the CP weight and BMI Z scores 
would be below average, due to selective weighing of children with poor weight gain.  
RESULTS  
There were 336 children coded as having CP in the database, born between 1997 (when 
growth was first recorded) and 2013. Of these 293 had at least one measurement and 195 had 
a GMFCS level recorded. The remainder did not have a score entered on the database and 
their pediatrician had not replied to our request for this extra information. This provided 480 
heights and 596 weights (see web table) with median (range) 2 (0-11) weights and 2 (0-15) 
heights per child children, aged 2-17 years.  
Using the UK-WHO reference, height and weight Z scores declined with increasing 
CP severity, with median height Z score for GMFCS V close to the UK-WHO 2nd percentile 
(figure 1). In contrast, with the CP reference and the appropriate GMFCS level chart, median 
height and weight were between the 50th and 75th percentiles for all GMFCS levels, while 
BMI was consistently close to the 50th percentile.  Table 1 shows the corresponding Z score 
means and SDs. In terms of formal criteria, the fit to the CP reference was good or acceptable 
(i.e., within 0.67 SD) at all levels for weight and BMI, and for height at all levels except III 
and V.  Using  the UK-WHO, there was a poor fit for height from GMFCS levels II to V, for 
weight at levels IV and V, and BMI at level V.  The SDs of the Z scores for UK-WHO were 
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usually greater than 1 (range 0.9 to 2), while they were less than 1 (range 0.5 to 1) for the CP 
reference. 
Compared to the UK charts by age of measurement there was large divergence in 
height from age 2 years, with little overall evidence of an age trend. However it was really 
only those with more severe CP who were consistently discrepant from the UK 1990 
reference (figure 2) and their discrepancy tended to increase with age (table 2). In contrast 
there was a trend to increasing weight and BMI Z scores with age in all severities when 
compared to the CP reference (table 2). These analyses were repeated in the per child dataset 
and similar effects were seen (data not shown).   
DISCUSSION 
Recognizing the limited growth potential of many severely disabled children is important to 
avoid invasive feeding approaches when they are not needed. While some children will 
require gastrostomy feeding due to unsafe swallow, there is the risk that others are tube fed 
due to a misperception that they are nutritionally compromised. Recent studies have 
demonstrated that when tube fed these children often have very modest requirements19and 
tend to become overfat20.  Equally, it is important not to simply assume that all is well in 
child with CP with falling percentiles. What is needed is a valid reference for comparison and 
these charts appear to go a long way in providing this, although they can only be seen as a 
description of how such children grow, rather than a standard of optimal growth.   
Compared to the UK reference, the height and weight deficit of children with CP was 
very pronounced and present from age 2 years. To our surprise the deficits increased only 
slightly with age, even in those with the most severe CP, which suggests that the slow growth 
trajectory in CP is set very early on.  The fit to the UK reference was much better generally 
for BMI, though the most severe children still fitted poorly. In contrast children showed 
acceptable fits to the California CP charts, though they tended to be somewhat taller in all 
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GMFCS levels, and those with more severe CP also tended to be heavier. The fit for BMI 
was better and showed the closest fit for those with more severe CP, with mean values 
tending to be slightly below the 50th percentile.   
There were limitations in this study.  Not all children with CP had growth data 
recorded electronically and many had only one or two data points. Working within a clinical 
system and dependent on the good will of many pediatricians, we were only able to identify a 
GMFCS level for two thirds of the children, but this should not have introduced any 
systematic bias. It still yielded data on nearly 200 children with a median of 2 weights and 2 
heights per child, and spanning the whole of childhood.  The relative sparsity of the data per 
child will inevitably raise concerns about their representativeness, with the risk that more 
measurements were collected at times when there were concerns about growth or weight 
gain. Thus in using single measurements there was a risk of  bias due to children with poor 
growth being measured more often than others21.  However, when using average values per 
individual child the numbers were small. Analysis of the data using both methods 
reassuringly yielded very similar results. We had very few data for later adolescence, at 
which point they may have been harder to measure. However the data points we had at these 
ages were consistent with earlier ages.   
 
The SDs of the Z scores based on the UK-WHO reference were all greater than the 
expected value of one, which may reflect a non-healthy sample being compared to a healthy 
reference. However based on the CP reference the SDs were all less than one, suggesting less 
than the expected level of variation.   Taken together with the relatively high height and 
weight Z scores, this suggests that UK children are bigger and less variable in anthropometric 
measures than the reference Californian children. Measurement of height and length is often 
challenging in children with CP, so that these differences might reflect differences in 
measurement method. The equipment used in both settings was not standardized and in the 
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UK the most severe and the oldest children tended not to be measured at all.  Contractures 
used to significantly limit measurement in CP, but these are now much less common due to 
early physiotherapy and splinting. However these factors would be expected to differentially 
affect length for the children with the most severe CP, when in fact mean heights/lengths   
were higher for all severities.   
Part of the explanation may be related to general demographics.  The Californian 
population was more heterogeneous with regard to ethnicity, with a large proportion of 
Hispanic individuals who tend to be shorter than non-Hispanic white persons of the same 
age22. To our knowledge differences in CP growth by ethnicity have not been studied 
directly, but a recent study by the Surveillance of Cerebral Palsy in Europe did find that 
anthropometric measures differed across countries in a pattern that seemed to relate to 
differing rates of enteral feeding23. Beyond general demographic considerations, it should be 
recognized that the British children were predominantly born and managed in the years 2000-
2010, around 10 years after most of the Californian children were measured. Studies from 
both the US and the UK24 25 have documented significant trends toward increased weight and 
BMI of children as measured in general pediatric practices from the early 1990s. In addition 
the study period is recognized as one of increased awareness of the risks of malnutrition in 
children with CP.  However, again this trend is seen consistently in all severities, particularly 
for height, and it seems unlikely that children with milder CP will have previously 
experienced undernutrition in childhood.  However, many of these children at all severities 
will have been born preterm, so it is possible that these differences could reflect better recent 
nutritional care as neonates.  
The Californian reference data showed that children who were tube fed were both 
heavier and taller than equally severe children who were not, which suggests that at least 
some of the growth deficit in severe CP reflects a nutritional deficit8.   In our sample we 
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could not reliably identify tube feeding status, and the British GMFCS V group showed an 
acceptable fit to the GMFCS V-NT California reference. Further research is necessary to 
validate the use of charts that are stratified by mode of feeding and to clarify how to classify 
children who commence or cease enteral feeding over time. 
Surprisingly, the best fit for the UK CP children was to the BMI charts.  BMI is not 
widely used in this population but it can be highly illuminating in small children where there 
is concern about possible undernutrition.  However, it is the measure most prone to error and 
in our practice we would always recommend use of skinfolds as well, as a more direct 
assessment of fat stores.   
In conclusion, UK children with severe CP plotted on conventional charts appear very 
small.  They fit the US CP charts much better, though tending to be heavier and taller than 
average. Presenting the US CP charts as LMS tables will make it possible to calculate 
GMFCS level specific Z scores, as well as to create paper charts using local chart formats. 
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Table 1: Z scores for height, weight and BMI based on UK 1990 and US Cerebral Palsy References, by GMFCS level 
Bold = good fit to standard (<0.33SD discrepancy from expected 0) 
Underlined = poor fit (>0.67 discrepancy) 
 
 
 
  UK 1990 reference Cerebral Palsy Reference 
Individual 
measurements 
Number of 
Height Weight BMI 
 
Height Weight BMI 
 GMFCS Heights Weights Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
I 150 157 -0.63 1.07 -0.30 1.23 0.09 1.28 0.38 0.54 0.07 0.79 -0.34 0.67 
II 131 135 -1.03 1.28 -0.37 1.50 0.37 1.38 0.40 0.61 0.25 0.94 -0.13 0.73 
III 60 72 -0.86 1.14 -0.59 1.53 0.07 1.59 0.80 0.56 0.50 0.86 -0.12 0.79 
IV 56 81 -1.79 1.43 -1.63 1.95 -0.41 1.96 0.49 0.62 0.20 1.02 -0.18 0.82 
V 83 151 -1.68 1.56 -1.52 1.77 -0.80 1.75 0.71 0.62 0.62 0.85 -0.26 0.74 
Average per 
child 
Number of 
children 
            I 52  -0.46 0.90 -0.22 1.08 0.03 1.15 0.48 0.46 0.13 0.71 -0.38 0.61 
II 43  -0.81 1.25 -0.35 1.38 0.25 1.30 0.51 0.60 0.26 0.86 -0.18 0.69 
III 26  -1.10 1.05 -0.59 1.43 0.11 1.39 0.67 0.50 0.50 0.80 -0.11 0.68 
IV 28  -1.70 1.34 -1.38 1.85 -0.32 1.89 0.54 0.58 0.35 0.97 -0.12 0.82 
V 46  -1.84 1.60 -1.69 1.61 -0.86 1.71 0.66 0.62 0.54 0.70 -0.24 0.66 
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Table 2: Z scores for individual height, weight and BMI based on UK 1990 and US Cerebral Palsy references, by age and severity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
†Linear regression 
 
 
  
UK 1990 reference Cerebral Palsy Reference 
  
Height 
 
Weight BMI 
 
Height 
 
Weight BMI 
 
 
Age 
(yrs) Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
GMFCS 2-4 -1.06 1.17 -0.37 1.27 0.38 1.22 0.51 0.56 0.26 0.83 -0.26 0.57 
I-III 4-6 -0.85 1.05 -0.51 1.43 0.13 1.51 0.49 0.49 0.14 0.92 -0.37 0.74 
 
6-8 -0.83 1.14 -0.55 1.43 0.04 1.34 0.42 0.50 0.10 0.87 -0.34 0.72 
 
8-10 -0.86 1.12 -0.38 1.41 0.18 1.38 0.27 0.56 0.18 0.85 -0.13 0.76 
 
10-12 -0.68 1.27 -0.22 1.80 0.35 1.67 0.28 0.70 0.25 1.07 0.07 0.89 
 
12-14 -0.34 1.40 0.01 1.45 0.18 1.37 0.62 0.79 0.46 0.85 0.03 0.71 
 
14-17 -0.62 1.28 -0.20 0.96 0.15 1.16 0.68 0.80 0.43 0.67 0.03 0.69 
 
P†  0.05 
 
0.14 
 
0.76 
 
0.70 
 
0.15 
 
0.001 
 
              IV-V 2-4 -1.29 1.44 -1.22 1.61 -0.40 1.68 0.70 0.62 0.24 0.88 -0.38 0.67 
 
4-6 -1.68 1.83 -1.73 2.31 -0.57 2.11 0.58 0.77 0.20 1.14 -0.33 0.83 
 
6-8 -2.14 1.35 -1.61 1.45 -0.75 2.12 0.51 0.57 0.41 0.71 -0.34 0.83 
 
8-10 -1.67 1.49 -1.30 1.87 -0.73 1.29 0.71 0.63 0.75 0.93 -0.18 0.61 
 
10-12 -1.89 1.14 -1.60 2.09 -1.07 2.06 0.62 0.51 0.73 1.04 -0.10 0.89 
 
12-14 -1.96 1.37 -1.52 1.50 -0.72 2.01 0.68 0.64 0.88 0.68 0.25 0.85 
 
14-17 -2.94 1.32 -2.43 1.52 -1.27 2.11 0.44 0.55 0.75 0.65 0.14 0.81 
 
P†  0.07 
 
0.04 
 
0.13 
 
0.88 
 
<0.001 
 
0.001 
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LEGENDS TO FIGURES 
 
 
Figure 1: Fit of individual measurements to CP and UK charts, by severity (GMFCS) 
Figure 2: Fit of individual measures to UK 1990 charts, by age and severity (GMFCS) 
 
 
 
 
 
 
 
